Clinical Effectiveness Of Omalizumab In Severe Allergic Asthma Above The Recommended Dosing Range: The Australian Xolair Registry
Citation
Hew, M, Gillman, A, Sutherland, M et al 2016, 'Clinical Effectiveness Of Omalizumab In Severe Allergic Asthma Above The Recommended Dosing Range: The Australian Xolair Registry', International Conference of the American-Thoracic-Society (ATS), American Thoracic Society, United States, pp. A1407.Year
2016ANU Authors
Fields of Research
- Respiratory Diseases
- Allergy